# Gendius

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gendius

- Industry: Healthcare IT
- Headquarters: Cheshire, UK
- Website: www.gendius.co.uk
- Total disclosed funding: $0.7M
- Latest round: Series A (Sep 28, 2017)
- Investors on record: 1

## About

Gendius Ltd is a health technology company focused on developing innovative solutions for diabetes management, enhancing patient care through data analytics and personalized monitoring tools.Founded in 2011 in Cheshire, UK, Gendius Ltd specializes in health technology solutions for chronic condition management. The company has pivoted its strategy towards enhancing digital health offerings. The CEO is Rory Cameron, and the founder is Chris Genders, who has experience in building technology-driven healthcare solutions. Gendius has raised GBP 0.12 mn in its latest funding round from Nolan Capital, which values the company at GBP 20.38 mn. To date, Gendius has completed a total of 3 deals, with the most recent deal occurring on October 5, 2020.Gendius.co.uk develops advanced health technology solutions aimed at enhancing diabetes management. Their flagship product is a digital platform that integrates data analytics with patient monitoring tools, enabling healthcare professionals to track glucose levels, dietary habits, and medication adherence. This platform is targeted at healthcare providers and patients in the UK and Europe, facilitating personalized treatment plans and improving patient engagement.Gendius generates revenue through subscription-based services and strategic partnerships with healthcare providers. Healthcare institutions pay for access to their digital platform, enabling patient management and monitoring. Gendius also offers its services directly to consumers, helping users manage their health through specialized tools and analytics.In October 2020, Gendius Ltd raised GBP 0.12 mn in venture financing led by Nolan Capital, which will be used to further develop their health technology solutions. The company is focused on expanding its product offerings, including new features for their digital platform aimed at enhancing user experience. Gendius also plans to enter additional European markets by 2025 to broaden its reach and improve health outcomes for a larger patient base.

## Funding rounds

- Series A, Sep 28, 2017, $0.7M — Catapult Ventures Group

## Investors

- Catapult Ventures Group (https://capitalatlas.ai/funds/catapult-ventures-group) — Series A